Current status of nanotechnology approaches for cardiovascular disease: A personal perspective

Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology

Volumn 1, Issue 2, 2009, Pages 149-155

  Buxton, Denis B ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIO-VASCULAR DISEASE; EFFECTIVE CONCENTRATION; FUNCTIONAL INFORMATION; NANOSTRUCTURED SURFACE; NEW TECHNOLOGIES; PERSONAL PERSPECTIVE; RAPID GENOTYPING; REPAIR MECHANISM;

BIOCHEMISTRY; BIOMEDICAL EQUIPMENT; DIAGNOSIS; DISEASES; DRUG DELIVERY; DRUG DOSAGE; DRUG INTERACTIONS; MOLECULAR IMAGING; NANOPARTICLES; NANOTECHNOLOGY; REPAIR; TISSUE REGENERATION;

SCAFFOLDS (BIOLOGY);

DIAGNOSTIC AGENT; DRUG CARRIER; NANOPARTICLE;

ARTICLE; CARDIOVASCULAR DISEASE; CHEMISTRY; FORECASTING; GENETIC PROCEDURES; INSTRUMENTATION; NANOMEDICINE; SYNTHESIS; UNITED STATES;

BIOSENSING TECHNIQUES; CARDIOVASCULAR DISEASES; DRUG CARRIERS; FORECASTING; NANOMEDICINE; NANOPARTICLES; UNITED STATES;

EID: 77949312337     PISSN: 19395116     EISSN: 19390041     Source Type: Journal    
DOI: 10.1002/wnan.8     Document Type: Article

References (26)

1. Rosamond W, Flegal K, Friday G, Furie K, Go A, et al. Heart disease and stroke statistics-2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007, 115:e69-171.
2. Dobson MG, Galvin P, Barton DE. Emerging technologies for point-of-care genetic testing. Expert Rev Mol Diagn 2007, 7:359-370.
3. Bao YP, Huber M, Wei TF, Marla SS, Storhoff JJ, et al. SNP identification in unamplified human genomic DNA with gold nanoparticle probes. Nucleic Acids Res 2005, 33:e15.
4. Georganopoulou DG, Chang L, Nam JM, Thaxton CS, Mufson EJ, et al. Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer's disease. Proc Natl Acad Sci U S A 2005, 102:2273-2276.
5. Goluch ED, Nam JM, Georganopoulou DG, Chiesl TN, Shaikh KA, et al. A bio-barcode assay for on-chip attomolar-sensitivity protein detection. Lab Chip 2006, 6:1293-1299.
6. Jaffer FA, Libby P, Weissleder R. Molecular and cellular imaging of atherosclerosis: emerging applications. J Am Coll Cardiol 2006, 47:1328-1338.
7. Nahrendorf M, Jaffer FA, Kelly KA, Sosnovik DE, Aikawa E, et al. Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis. Circulation 2006, 114:1504-1511.
8. Hyafil F, Cornily JC, Feig JE, Gordon R, Vucic E, et al. Noninvasive detection of macrophages using a nanoparticulate contrast agent for computed tomography. Nat Med 2007, 13:636-641.
9. Doyle B, Caplice N. Plaque neovascularization and antiangiogenic therapy for atherosclerosis. J Am Coll Cardiol 2007, 49:2073-2080.
10. Winter PM, Neubauer AM, Caruthers SD, Harris TD, Robertson JD, et al. Endothelial alpha(v)beta3 integrintargeted fumagillin nanoparticles inhibit angiogenesis in atherosclerosis. Arterioscler Thromb Vasc Biol 2006, 26:2103-2109.
11. Rozema DB, Lewis DL, Wakefield DH,Wong SC, Klein JJ, et al. Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytes. Proc Natl Acad Sci U S A 2007, 104:12982-12987.
12. Leite EA, Grabe-Guimaraes A, Guimaraes HN, Machado-Coelho GLL, Barratt G, et al. Cardiotoxicity reduction induced by halofantrine entrapped in nanocapsule devices. Life Sci 2007, 80:1327-1334.
13. O'BrienMER,WiglerN, InbarM, Rosso R, Grischke E, et al. Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYXTM/Doxil(R)) versus conventional doxorubicin for first-line treatment of metastatic breast cancer. Ann Oncol 2004, 15:440-449.
14. Stankus JJ, Soletti L, Fujimoto K, Hong Y, Vorp DA, et al. Fabrication of cell microintegrated blood vessel constructs through electrohydrodynamic atomization. Biomaterials 2007, 28:2738-2746.
15. Hashi CK, Zhu Y, Yang G-Y, Young WL, Hsiao BS, et al. Antithrombogenic property of bone marrow mesenchymal stem cells in nanofibrous vascular grafts. Proc Natl Acad Sci 2007, 104:11915-11920.
16. Millon LE, Wan WK. The polyvinyl alcohol-bacterial cellulose system as a new nanocomposite for biomedical applications. J Biomed Mater Res B Appl Biomater 2006, 79B:245-253.
17. Brody S, Anilkumar T, Liliensiek S, Last JA, Murphy CJ, et al. Characterizing nanoscale topography of the aortic heart valve basement membrane for tissue engineering heart valve scaffold design. Tissue Eng 2006, 12:413-421.
18. Ishii O, Shin M, Sueda T, Vacanti JP. In vitro tissue engineering of a cardiac graft using a degradable scaffold with an extracellular matrix-like topography. J Thorac Cardiovasc Surg 2005, 130:1358-1363.
19. Zong X, Bien H, Chung CY, Yin L, Fang D, et al. Electrospun fine-textured scaffolds for heart tissue constructs. Biomaterials 2005, 26:5330-5338.
20. Davis ME, Motion JP, Narmoneva DA, Takahashi T, Hakuno D, et al. Injectable self-assembling peptide nanofibers create intramyocardial microenvironments for endothelial cells. Circulation 2005, 111:442-450.
21. Hsieh PC, Davis ME, Gannon J, MacGillivray C, Lee RT. Controlled delivery of PDGF-BB for myocardial protection using injectable self-assembling peptide nanofibers. J Clin Invest 2006, 116:237-248.
22. Davis ME, Hsieh PC, Takahashi T, Song Q, Zhang S, et al. Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction. Proc Natl Acad Sci U S A 2006, 103:8155-8160.
23. Segers VF, Tokunou T, Higgins LJ, MacGillivray C, Gannon J, et al. Local delivery of protease-resistant stromal cell derived factor-1 for stem cell recruitment after myocardial infarction. Circulation 2007, 116:1683-1692.
24. Bhargava B, Reddy NK, Karthikeyan G, Raju R, Mishra S, et al. A novel paclitaxel-eluting porous carbon-carbon nanoparticle coated, nonpolymeric cobalt-chromium stent: evaluation in a porcine model. Catheter Cardiovasc Interv 2006, 67:698-702.
25. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, et al. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med 2001, 345:1435-1443.
26. http://www.acrymed.com/medical.html (2008).